Holistic management with a view to comorbidities

Antiretroviral therapy (ART) has developed enormously over the last 40 years. Data from the “Swiss HIV Cohort Study” show that the life expectancy of HIV patients today hardly differs from that of the general population. Combination therapies have been optimized not only in terms of drug composition, but also in terms of dosage form. Nevertheless, the topics of multimorbidity and polypharmacy are still very topical today. There are interesting new studies on this.